Crossmark

CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL)

Published Online: 2024-08-09

Published Print: 2024-11

Authors

Galli, Eugenio

Corrente, Alessandro

Chiusolo, Patrizia https://orcid.org/0000-0002-1355-1587
Sica, Simona https://orcid.org/0000-0003-2426-3465
Sorà, Federica https://orcid.org/0000-0002-9607-5298
License Information

Text and Data Mining valid from 2024-08-09

Version of Record valid from 2024-08-09
More Information

Article History

Received: 8 July 2024

Revised: 25 July 2024

Accepted: 29 July 2024

First Online: 9 August 2024

Competing interests

: EG, SS and FS received grants from Kite Gilead. The authors declare no other competing conflicts of interest.

Document is current